Novel Process for 3D Printing Decellularized Matrices
January 7th, 2019
6.7K views
This protocol describes the production of polycaprolactone (PCL) filament with embedded polylactic acid (PLA) microspheres which contain decellularized matrices (DM) for 3D printing of structural tissue engineering constructs.
Overview
This protocol describes a method for co-printing structural synthetics and biologic components to create tissue-engineered scaffolds. These scaffolds can more accurately replicate the native tissue environment, benefiting cultured cells.
Key Study Components
Area of Science
- Tissue Engineering
- 3D Printing
- Biomaterials
Background
- Decellularized matrices (DM) are used to enhance scaffold functionality.
- Polycaprolactone (PCL) and polylactic acid (PLA) are key materials in scaffold production.
- Microspheres can encapsulate biologic materials without damaging them.
- This technique allows for the integration of mechanical and biological properties in scaffolds.
Purpose of Study
- To produce mechanically sound tissue-engineered scaffolds.
- To encapsulate decellularized matrices within microspheres for enhanced cell culture.
- To develop a method that combines structural and biologic components in one printing process.
Methods Used
- Production of PCL filament with embedded PLA microspheres.
- Use of decellularized cartilage from porcine hind limbs.
- 3D printing techniques for scaffold fabrication.
- Characterization of microsphere size and properties.
Main Results
- Successfully created scaffolds that maintain structural integrity.
- Demonstrated the ability to encapsulate biologic materials effectively.
- Showed improved cell culture conditions within the scaffolds.
- Validated the method for producing complex tissue-engineered constructs.
Conclusions
- This method enhances the potential for creating functional tissue scaffolds.
- Co-printing techniques can bridge the gap between synthetic and biologic materials.
- Future applications may include regenerative medicine and tissue repair.
Frequently Asked Questions
What materials are used in this protocol?
The protocol uses polycaprolactone (PCL) and polylactic acid (PLA) along with decellularized matrices.
How does this method benefit cell culture?
It creates scaffolds that replicate the native tissue environment, improving conditions for cultured cells.
What is the significance of using decellularized matrices?
Decellularized matrices provide a natural environment for cells, enhancing scaffold functionality.
Can this method be applied to other types of tissues?
Yes, the technique can potentially be adapted for various tissue types in regenerative medicine.
What are the advantages of 3D printing in tissue engineering?
3D printing allows for precise control over scaffold architecture and integration of multiple materials.
What challenges does this method address in tissue engineering?
It addresses the challenge of combining mechanical strength with biological compatibility in scaffolds.
Executive Industry Relevance
Integrating decellularized matrices within 3D-printed scaffolds enables the creation of tissue-engineered constructs that combine mechanical integrity with biologic functionality. This approach addresses a critical challenge in early discovery and preclinical research by preserving bioactivity during fabrication, supporting predictive confidence in tissue modeling. The method positions bioprinting as a platform for developing disease-relevant systems and advancing translational biomaterials research.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of cell-matrix interactions in a controlled 3D environment.
- Supports functional validation of biomaterial cues for progenitor cell behavior.
- Facilitates mechanistic de-risking by preserving biologic agent activity during scaffold fabrication.
- Improves predictive confidence in tissue engineering hypotheses.
Screening & Assay Development
- Provides standardized, reproducible 3D scaffolds for downstream cell-based assays.
- Enables quantitative comparison of scaffold surface features and cell responses.
- Supports assay scalability and platform reuse for compound or biomaterial screening.
- Prepares validated biological systems for reliable evaluation of regenerative cues.
Translational & Preclinical Research
- Aligns scaffold composition with disease-relevant tissue environments for translational studies.
- Enables continuity from discovery through preclinical validation of tissue repair strategies.
- Supports risk-adjusted advancement decisions by maintaining biologic function in constructs.
- Facilitates in vitro and in vivo assessment of scaffold performance.
Pipeline & Workflow Integration
This method bridges early discovery, assay development, and preclinical research by enabling the fabrication of biologically active, mechanically robust 3D scaffolds.
- Discovery Biology: Supports hypothesis testing on cell-matrix interactions and biological de-risking.
- Screening: Delivers reproducible, quantitative scaffold outputs for assay readiness.
- Analytics: Provides measurable surface features and composition for comparative analysis.
- Translational Research: Maintains functional biomaterial cues for preclinical model alignment.
- Enterprise Reuse: Establishes a reusable workflow for diverse tissue engineering applications.
Operational & Enterprise Impact
- Scientific Value: Enhances predictive confidence and target validation in tissue engineering.
- Operational Value: Standardizes scaffold production with reproducible and scalable outputs.
- Strategic Value: Reduces late-stage biological risk and supports efficient go/no-go decisions.
- Portfolio Impact: Enables risk-adjusted prioritization of regenerative medicine programs.
Implementation Considerations
- Requires expertise in biomaterials processing and 3D printing instrumentation.
- Demands analytical infrastructure for scaffold characterization and quality control.
- Necessitates cross-team standardization of microsphere preparation and extrusion parameters.
- Adaptation may be needed for different tissue types or biologic agents.
- Proper handling of particulates and batch scaling are essential for reproducibility and safety.
Biopharma FAQs
Why does null hypothesis testing matter for scaffold surface feature analysis?
Null hypothesis testing enables objective comparison of surface features between PLA-DM/PCL and PCL-only scaffolds, supporting target validation of biologic incorporation effects in tissue engineering constructs.
How does independent variable isolation fit the microsphere sieving workflow?
Isolating microsphere size as an independent variable ensures consistent flow dynamics during extrusion, allowing reliable assessment of scaffold fabrication parameters in the discovery pipeline.
What do quantitative dependent variable measurements enable in scaffold evaluation?
Quantitative measurements of filament diameter and surface morphology provide reproducible outputs for comparing scaffold batches and optimizing 3D printing conditions for downstream applications.
Why are replication requirements critical for cross-functional scaffold production?
Replication ensures that scaffold properties are consistent across batches, facilitating collaboration between biomaterials, analytical, and translational teams for reliable preclinical studies.
What statistical analysis capabilities are required before scaffold implementation?
Statistical analysis of scaffold uniformity, microsphere distribution, and surface features is essential to validate reproducibility and inform go/no-go decisions in tissue engineering workflows.
